Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS

Molecular Cancer Therapeutics

Volumn 2, Issue 11, 2003, Pages 1165-1170

  Pardhasaradhi, Bobbili V V ^a   Mubarak Ali, A ^a   Leela Kumari, A ^a   Reddanna, Pallu ^b   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DNA FRAGMENT; ISOENZYME; PHYCOCYANIN; PROSTAGLANDIN SYNTHASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL; APOPTOSIS; ARTICLE; CYANOBACTERIUM; DOWN REGULATION; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CYANOBACTERIA; CYCLOOXYGENASE 2; DNA FRAGMENTATION; DOWN-REGULATION; ISOENZYMES; NEOPLASMS; PHYCOCYANIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 2942522606     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Romay, C., Armesto, J., Ramirez, D., Gonzalaz, R., Ledon, N., and Garcia, I. Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm. Res., 47: 36-41, 1998. (Pubitemid 28048114)
2. Gonzalez, R., Rodriguez, S., Romay, C., Ancheta, O., Gonzalez, A., Armesto, J., Ramirez, D., and Merino, N. Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Pharmacol. Res., 39: 55-59, 1999.
3. Bhat, V. B. and Madyastha, K. M. C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro . Biochem. Biophys. Res. Commun., 275: 20-25, 2000. (Pubitemid 30663622)
4. Williams, C. S., Mann, M., and DuBois, R. N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18: 7908-7915, 1999.
5. Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., and Subbaramaiah, K. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2: 544-551, 2001. (Pubitemid 33586867)
6. Bandoopadhyay, G. K., Imagawa, W., Wallace, D., and Nandi, S. Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J. Biol. Chem., 262: 2750-2756, 1987. (Pubitemid 17105667)
7. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
8. Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., and DuBois, R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res., 58: 362-366, 1998. (Pubitemid 28047080)
9. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
10. Reddy, C. M., Bhat, V. B., Kiranmai, G., Reddy, M. N., Reddanna, P., and Madhyastha, K. M. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis . Biochem. Biophys. Res. Commun., 277: 599-603, 2000.
11. Khar, A. Development and characterization of a rat histiocyte-macrophage tumor line. J. Natl. Cancer Inst., 76: 871-878, 1986. (Pubitemid 16121945)
12. Khar, A. and Ali, A. M. Adaptation of rat histiocytoma cells AK-5, to growth in culture. In Vitro Cell. Dev. Biol., 26: 1024-1025, 1990.
13. Anjum, R., Joshi, P., and Khar, A. Induction of apoptosis in AK-5 tumor cells by a serum factor from tumor rejecting animals: cytochrome c release independent of Bcl-2 and caspases. Cell Death Differ., 8: 1038-1046, 2001. (Pubitemid 32994653)
14. Gong, J., Traganos, F., and Darzynkiewicz, Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218: 314-319, 1994. (Pubitemid 24141629)
15. Pick, E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol., 132: 407-421, 1986. (Pubitemid 17233588)
16. 2 in cultured endothelial cells. Arch. Biochem. Biophys., 302: 348-352, 1993.
17. Dimmeler, S., Haendeler, J., Nehls, M., and Zeiher, A. M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med., 185: 601-607, 1997. (Pubitemid 27098145)
18. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
19. Parrett, M. L., Harris, R. E., Joarder, F. S., Ross, M. S., Clausen K. F., and Robertson, F. M. Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol., 10: 503-507, 1997. (Pubitemid 27122013)
20. Hida, T., Yataba, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998. (Pubitemid 28405625)
21. Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T., and Wada, S. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer (Phila.), 89: 589-596, 2000. (Pubitemid 30640105)
22. Tang, X., Sun, Y. J., Half, E., Kuo, T., and Sinicrope, F. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res., 62: 4903-4908, 2002. (Pubitemid 34984412)
23. Howe, L. R., Subbaramaiah, K., Patel, J., Masferrer, J. L., Deora, A., Hudis, C., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M., and Dannenberg, A. J. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res., 62: 5405-5407, 2002.
24. Kundu, N. and Fulton, A. M. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res., 62: 2343-2346, 2002. (Pubitemid 34411715)
25. Voehringer, D. W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med., 27: 945-950, 1999. (Pubitemid 29507468)
26. Khar, A., Ali, A. M., Pardhasaradhi, B. V. V., Varalakshmi, Ch., Anjum, R., and Kumari, A. L. Induction of stress response renders human tumor cell lines resistant to curcumin mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones, 6: 368-376, 2001. (Pubitemid 33123490)
27. Hockenbery, D. M., Oltavi, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993. (Pubitemid 23320288)
28. Voehringer, D. W., McConkey, D. J., McDonnel, T. J., Brisbay, S., and Meyn, R. E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA, 95: 2956-2960, 1998. (Pubitemid 28135836)
29. Hengartner, M. O. The biochemistry of apoptosis. Nature, 407: 770-776, 2000.
30. Amstad, P. A., Liu, H., Ichimiya, M., Berezesky, I. K., Trump, B. F., Buhimchi, I. A., and Gutierrez, P. L. Bcl-2 is involved in preventing oxidant induced cell death and in decreasing oxygen radical production. Redox Rep. 6: 351-362, 2001. (Pubitemid 34134326)
31. Shimizu, S., Eguchi, Y., Kamiike, W., Funahashi, Y., Mignon, A., Lacronique, V., Matsuda, H., and Tsujimoto, Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. USA, 95: 1455-1459, 1998. (Pubitemid 28103413)